{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:42:53Z","timestamp":1787503373961,"version":"build-2736575974"},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2016.52.4.2470954","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T06:52:03Z","timestamp":1678776723000},"page":"249","source":"Crossref","is-referenced-by-count":22,"title":["Venetoclax: Bcl-2 inhibition for the treatment of chronic\nlymphocytic leukemia"],"prefix":"10.3730","volume":"52","author":[{"family":"Del Poeta, G.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Postorino, M.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pupo, L.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"et al.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2016]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T09:43:52Z","timestamp":1685439832000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddk86f"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2016.52.4.2470954","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}